FROM LAB TO LIFE BRIDGING SCIENCE AND CARE

FDD Conclave 2025 spotlights patient-centric pharma innovation, uniting industry leaders to shape the future of formulation and drug delivery

- 

Inaugural Session

The inaugural session of FDD Conclave 2025 set a powerful tone for the two-day event that united the industry’s brightest minds in FR&D to spur patient-centric innovation. It began with an inaugural address by Viveka Roychowdhury, Editor, Express Pharma and Express Healthcare. Spotlighting the event’s central theme — “From lab to life: Bridging science and care”, she underscored the need to humanise innovation in drug formulation and delivery. She emphasised that beyond scientific breakthroughs, true success lies in creating solutions that improve patient outcomes and quality of life.

She explained the vision and mission behind setting up the FDD Conclave and thanked the industry for its unwavering support in building the platform and making it successful.

This was followed by a ceremonial lamp lighting, marking the auspicious start of the conclave. Key dignitaries on stage included Roychowdhury, Manish Jain, MD, Cilicant, and Vijay Doshi, MD, Pioma Chemicals, Suresh Pareek, Angel Investor and Rajesh Bhatkal, GM, Express Pharma.

The inaugural session laid the foundation for engaging dialogues and forward-thinking strategies to shape FR&D in India.

Formulation strategies for complex injectables

At the FDD Conclave 2025, Dr. Ajay Jaysingh Khopade, VP FR&D, Sun Pharmaceutical Industries, delivered an insightful presentation that delved into the future roadmap, challenges, and opportunities surrounding formulation strategies for complex injectables.